Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

BACKGROUND: The safety and efficacy of the AZD1222 (ChAdOx1 nCoV-19) vaccine in a large, diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States, Chile, and Peru has not been known. METHODS: In this ongoing, double-blind, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Falsey, Ann R., Sobieszczyk, Magdalena E., Hirsch, Ian, Sproule, Stephanie, Robb, Merlin L., Corey, Lawrence, Neuzil, Kathleen M., Hahn, William, Hunt, Julie, Mulligan, Mark J., McEvoy, Charlene, DeJesus, Edwin, Hassman, Michael, Little, Susan J., Pahud, Barbara A., Durbin, Anna, Pickrell, Paul, Daar, Eric S., Bush, Larry, Solis, Joel, Carr, Quito Osuna, Oyedele, Temitope, Buchbinder, Susan, Cowden, Jessica, Vargas, Sergio L., Benavides, Alfredo Guerreros, Call, Robert, Keefer, Michael C., Kirkpatrick, Beth D., Pullman, John, Tong, Tina, Isaacs, Margaret Brewinski, Benkeser, David, Janes, Holly E., Nason, Martha C., Green, Justin A., Kelly, Elizabeth J., Maaske, Jill, Mueller, Nancy, Shoemaker, Kathryn, Takas, Therese, Marshall, Richard P., Pangalos, Menelas N., Villafana, Tonya, Gonzalez-Lopez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522798/
https://www.ncbi.nlm.nih.gov/pubmed/34587382
http://dx.doi.org/10.1056/NEJMoa2105290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522798/
https://www.ncbi.nlm.nih.gov/pubmed/34587382
http://dx.doi.org/10.1056/NEJMoa2105290

Ejemplares similares